The PRB-dependent FOXO1/IGFBP-1 axis is essential for progestin to inhibit endometrial epithelial growth

Mitsuhiro Nakamura1, Masahiro Takakura, Reina Fujii

  • 1Department of Obstetrics and Gynecology, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.

Cancer Letters
|April 23, 2013
PubMed

Insights

Progestin inhibits endometrial growth via progesterone receptor B (PRB), not PRA. The study reveals the FOXO1/IGFBP-1 pathway is crucial for PRB-mediated growth inhibition, offering therapeutic insights.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Gynecologic Oncology

Background:

  • Progestins regulate endometrial growth through progesterone receptors (PR).
  • Distinct roles of PR subtypes (PRA and PRB) in endometrial proliferation remain unclear.
  • Understanding PR signaling is vital for treating endometrial disorders.

Purpose of the Study:

  • To elucidate the specific signaling pathways of progestin in inhibiting endometrial epithelial cell growth.
  • To investigate the differential roles of PRA and PRB in mediating progestin's effects.
  • To identify key molecular mediators of progestin-induced endometrial growth inhibition.

Main Methods:

  • Established immortalized endometrial epithelial cells with stable PRA or PRB expression.
  • Utilized RT-PCR, cDNA microarray, siRNA knockdown, luciferase reporter assays, and chromatin immunoprecipitation.
  • Assessed in vitro cell growth inhibition following progestin treatment.

Main Results:

  • Progestin-induced growth inhibition was primarily mediated by PRB, not PRA.
  • Progestin upregulated FOXO1 in a PRB-dependent manner.
  • The FOXO1/IGFBP-1 axis was identified as essential for PRB-mediated endometrial cell growth inhibition, with FOXO1 acting upstream of IGFBP-1.

Conclusions:

  • PRB plays a dominant role in mediating progestin's growth-inhibitory effects on endometrial epithelial cells.
  • The FOXO1/IGFBP-1 signaling axis is a critical downstream pathway for PRB function.
  • Targeting the FOXO1/IGFBP-1 pathway may enhance progestin efficacy in endometrial therapies.

Related Concept Videos

Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Ovarian Cycle01:27

Ovarian Cycle

The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle length...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...